The Novo Nordisk Foundation chooses Eviden to build “Gefion” in Denmark

Eviden has won a new contract with the Danish Centre for AI Innovation, owned by the Novo Nordisk Foundation and the Export and Investment Fund of Denmark, to construct a state-of-the-art AI supercomputer in Denmark.

  • 8 months ago Posted in

The supercomputer is designed to cater to large-scale projects that utilize artificial intelligence and prioritize the highest level of security to support Danish data sovereignty. The new supercomputer is expected to be one of the most powerful AI supercomputers in the world. Its goal is to accelerate research and innovation in various fields such as healthcare, life sciences, and the green transition. It will deliver 6 Exaflops of FP8 AI performance and is based on the NVIDIA DGX SuperPODTM architecture. Eviden will deliver, install, and configure the supercomputer, as well as provide the maintenance and technical support during its entire lifetime.

The supercomputer, named Gefion, is expected to be ready for pilot projects before the end of the year. It will be housed in Denmark’s newly established national Centre for AI Innovation and will provide researchers from Denmark’s public and private sectors access to an advanced supercomputer optimized for AI.

“We’re proud to be working with Novo Nordisk Foundation and the Danish Centre for AI Innovation to deliver the AI supercomputer in Denmark to provide an unprecedented potential to accelerate groundbreaking scientific discoveries in areas such as drug discovery, disease diagnosis and treatment,” said Dr. Cédric Bourrasset, Head of HPC-AI and Quantum Computing, Eviden, Atos Group. “This new supercomputer will be a powerful resource to further boost AI research and collaboration between academia and Danish industry in Denmark’s already thriving AI-based research ecosystem.”

Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation, said, “Eviden is renowned for being the leading expert in AI supercomputing. They are therefore the ideal choice to support this exciting project and help Denmark’s brilliant researchers and innovators rise to the next level.”

“AI is helping researchers find solutions to many of humanity’s biggest challenges in healthcare, sustainability, energy and more” said Charlie Boyle, Vice President, DGX platforms at NVIDIA. “Built by Eviden with NVIDIA DGX H100 AI supercomputing, the Novo Nordisk Foundation Gefion system can advance research and development in Denmark with transformative, full-stack AI infrastructure.” Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. Its vision is to improve people’s health and the sustainability of society and the planet, and its mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.

Dell Technologies continues to make enterprise AI adoption easier with the Dell AI Factory,...
El Capitan, powered by the AMD Instinct MI300A APU, becomes the second AMD supercomputer to surpass...
Talent and training partner, mthree, which supports major global tech, banking, and business...
New AI-ready scale-out networking offering.
NetApp has updated its portfolio of enterprise storage offerings including new NetApp AFF A-Series...
CTERA has launched the next generation of CTERA Insight, a powerful visualization and analytics...
Infinidat has introduced its Retrieval-Augmented Generation (RAG) workflow deployment architecture...
With a flagship campus in Coventry, UK, the Coventry University Group operates and delivers in both...